REACH InsightsDanielle Drayton2026-05-20T17:50:49+00:00

REACH Insights

Five Routes to Market Relevance in AML: Differentiation by Unmet Need

May 20th, 2026|

What the FSGS Market Shift Means for Commercial Strategy

April 14th, 2026|

What We Can Expect from the Next Wave of ATTR-CM Therapies

March 24th, 2026|

Systemic Lupus Erythematosus (SLE): A Market in Transition

February 27th, 2026|

Five Routes to Market Relevance in AML: Differentiation by Unmet Need

Danielle Drayton2026-06-15T15:40:14+00:00May 20th, 2026|

What the FSGS Market Shift Means for Commercial Strategy

Amanda Theocles2026-06-10T18:59:03+00:00April 14th, 2026|

What We Can Expect from the Next Wave of ATTR-CM Therapies

Amanda Theocles2026-06-10T18:55:55+00:00March 24th, 2026|

Systemic Lupus Erythematosus (SLE): A Market in Transition

Amanda Theocles2026-06-10T18:53:03+00:00February 27th, 2026|

Previous 234 Next